TITLE

The effects of cranberry on glucose levels and HbAlC with type 2 diabetes patients- a randomized clinical trial

AUTHOR(S)
Gorji, A.; Soltani, R.; Keshvari, M.; Ghanadian, M.; Asgary, S.; Sarafzadegan, N.
PUB. DATE
December 2014
SOURCE
Journal of Shahrekord University of Medical Sciences;Dec2014/Jan2015, Vol. 16 Issue 5, p115
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Diabetes mellitus is a common endocrine disorder that affects 100 million people annually. It is considered as an important risk factor for clinical disorders such as nephropathy, neuropathy, retinopathy and cardiovascular diseases. The aim of this study was to examine the effects of cranberry (Cornus mas L.) on blood glucose and HbAlC levels in patients with type 2 diabetes. Methods: This randomized clinical trial, double-blind, placebo-controlled performed in the period of 6 weeks. 60 patients aged 41-65 years with diabetes participated in the study. Patients were randomly divided into control, consumer capsule placebo (n= 30) and group use, Cornus mas capsules. At the beginning and end of the study, fasting blood sugar (FBS), and glycosylated hemoglobin (HbAlc) were measured using t-test and ANCOVA. Results: There was no significant difference between the groups at baseline about the characteristics of the subjects (FBS, HbAlc, age). Cornus mas group compared with the control group receiving at the end of 6 weeks, the factors FBS and HbAlc decreased significantly (P< 0.05). Conclusion: Reducing FBS and HbAlc in patients with diabetes consumed Cornus mas for control is valuable. These changes in fasting blood glucose and glycosylated hemoglobin levels may be the result of anthocyanin compounds in the level of Cornus mas.
ACCESSION #
99642040

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics